BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 9614914)

  • 1. BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function.
    Arlt MF; Xu B; Durkin SG; Casper AM; Kastan MB; Glover TW
    Mol Cell Biol; 2004 Aug; 24(15):6701-9. PubMed ID: 15254237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability in patients with chronic B-cell lymphocytic leukaemia.
    Niv E; Bomstein Y; Yuklea M; Lishner M
    Br J Cancer; 2005 Apr; 92(8):1517-23. PubMed ID: 15812543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of aphidicolin-induced common fragile sites in peripheral lymphocyte chromosomes of patients with B-cell chronic lymphocytic leukemia.
    Nayak BN; Ray M
    Cancer Genet Cytogenet; 1989 May; 39(1):99-102. PubMed ID: 2499414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of fragile sites in childhood acute lymphoblastic leukemia patients and normal controls.
    Rao PN; Heerema NA; Palmer CG
    Hum Genet; 1988 Aug; 79(4):329-34. PubMed ID: 2970424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer chromosome breakpoints and common fragile sites induced by aphidicolin.
    Hecht F; Glover TW
    Cancer Genet Cytogenet; 1984 Oct; 13(2):185-8. PubMed ID: 6434179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile sites induced by FUdR, caffeine, and aphidicolin. Their frequency, distribution, and analysis.
    Rao PN; Heerema NA; Palmer CG
    Hum Genet; 1988 Jan; 78(1):21-6. PubMed ID: 2962925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous and aphidicolin-sensitive fragile site 3cen co-localizes with the (TTAGGG)n telomeric sequence in Chinese hamster cells.
    Musio A; Rainaldi G; Sbrana I
    Cytogenet Cell Genet; 1996; 75(2-3):159-63. PubMed ID: 9040784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous breakage and fragile site expression in chronic lymphocytic leukemia.
    Fundia A; Giere I; Larripa I; Slavutsky I
    Cancer Genet Cytogenet; 1998 Jun; 103(2):144-8. PubMed ID: 9614914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile sites and bladder cancer.
    Moriarty HT; Webster LR
    Cancer Genet Cytogenet; 2003 Jan; 140(2):89-98. PubMed ID: 12645645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations in cancer as a result of breakage at fragile sites.
    Popescu NC
    Cancer Lett; 2003 Mar; 192(1):1-17. PubMed ID: 12637148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common fragile sites as targets for chromosome rearrangements.
    Arlt MF; Durkin SG; Ragland RL; Glover TW
    DNA Repair (Amst); 2006 Sep; 5(9-10):1126-35. PubMed ID: 16807141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common fragile sites and cancer: targeted cloning by insertional mutagenesis.
    Büttel I; Fechter A; Schwab M
    Ann N Y Acad Sci; 2004 Dec; 1028():14-27. PubMed ID: 15650228
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.